Mycoplasma Bovis Bacterin

Biomune Company received full U.S. Department of Agriculture license approval for Mycomune,™a vaccine for the prevention of mastitis in dairy cows caused by Mycoplasma bovis and reduces duration and severity of M. bovis mastitis.

Mycoplasma mastitis has risen dramatically in incidence and is costly due to the lack of effective treatment for the disease, the company says.

For fastest response, call

(800) 846-0230

www.Biomune Company.com